Prevalence and factors associated with continual opioid use among patients attending methadone clinic at Mwananyamala Hospital, Dar Es Salaam, Tanzania

UNODC, 2016 Zawilska, 2015, ‘Legal Highs’--An Emerging Epidemic of Novel Psychoactive Substances, Int. Rev. Neurobiol., 120, 273, 10.1016/bs.irn.2015.02.009 Kolliakou, 2016, Novel psychoactive substances: an investigation of temporal trends in social media and electronic health records, Eur. Psychiatry, 38, 15, 10.1016/j.eurpsy.2016.05.006 Palamar, 2015, Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting, Drug Alcohol Depend., 156, 112, 10.1016/j.drugalcdep.2015.08.028 King, 2013, Legal classification of novel psychoactive substances: an International comparison, 3 Nosyk, 2014, High Levels of Opioid Analgesic Co ‐ Prescription Among Methadone Maintenance Treatment Clients in British Columbia, Canada : Results from a Population ‐ Level Retrospective Cohort Study, Am. J. Addict., 23, 257, 10.1111/j.1521-0391.2014.12091.x Gomes, 2014, The burden of premature opioid-related mortality, Addiction, 109, 1482, 10.1111/add.12598 UNODC, 2018 Chung, 2016, Trends of novel psychoactive substances (NPSs) and their fatal cases, Forensic Toxicol., 34, 1, 10.1007/s11419-015-0286-5 Kelty, 2017, Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone, Int. J. Drug Policy, 46, 54, 10.1016/j.drugpo.2017.05.039 C. for D. C. and P. (CDC), 2019, Vital signs: overdoses of prescription opioid pain relievers: United States, 1999-2008, MMWR Morb. Mortal. Wkly. Rep., 60, 1487 Fairbairn, 2017, Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic, Int. J. Drug Policy, 46, 172, 10.1016/j.drugpo.2017.06.005 Ogeil, 2018, Pharmaceutical opioid overdose deaths and the presence of witnesses, Int. J. Drug Policy, 55, 8, 10.1016/j.drugpo.2017.12.020 N. S, 2009, Prevalence of alcohol consumption and hazardous drinking, tobacco and drug use in urban Tanzania, and their associated risk factors, Int. J. Environ. Res. Public Heal., 6, 1991, 10.3390/ijerph6071991 Maman, 2001, Women’s barriers to HIV-1 testing and disclosure: challenges for HIV-1 voluntary counselling and testing, AIDS Care - Psychol. Socio-Medical Asp. AIDS/HIV, 13, 595, 10.1080/09540120120063223 Tiberio, 2018, International Journal of Drug Policy Context and characteristics of illicit drug use in coastal and interior Tanzania, Int. J. Drug Policy, 51, 20, 10.1016/j.drugpo.2017.09.012 Palamar, 2016, Self-reported use of novel psychoactive substances among attendees of electronic dance music venues, Am. J. Drug Alcohol Abuse, 42, 624, 10.1080/00952990.2016.1181179 Palamar, 2016, Detection of ‘bath salts’ and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users, Drug Alcohol Depend., 161, 200, 10.1016/j.drugalcdep.2016.02.001 Li L, 2012, Concurrent heroin use among methadone maintenance clients in China, Addict. Behav., 37, 264, 10.1016/j.addbeh.2011.11.004 Wei, 2018, Prevalence of and factors associated with long-term concurrent use of stimulants and opioids among adults with Attention-Deficit/Hyperactivity disorder, JAMA Netw. Open, 1, e181152, 10.1001/jamanetworkopen.2018.1152 Albion, 2010, Contributing factors to methadone-related deaths in Ontario, Am. J. Forensic Med. Pathol., 31, 313, 10.1097/PAF.0b013e3181ca4b1e Helander, 2007, 55 B. C. B. A and R. L. D. M. D, 2014, 37 Best, 2000, Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment, Drug Alcohol Rev., 19, 9, 10.1080/09595230096093 L. J. Li, 2011, Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan,China, Drug Alcohol Depen., 116, 246, 10.1016/j.drugalcdep.2010.12.007 S. W. Group, 2013, 452 Remane, 2016, Recent advances of liquid chromatography–(tandem) mass spectrometry in clinical and forensic toxicology–An update, Clin. Biochem., 49, 1051, 10.1016/j.clinbiochem.2016.07.010 Montesano, 2016, Broad screening and identification of novel psychoactive substances in plasma by high-performance liquid chromatography-high-resolution mass spectrometry and post-run library matching, J. Anal. Toxicol., 40, 519, 10.1093/jat/bkw043 Helander, 2013, Identification of novel psychoactive drug use in Sweden based on laboratory analysis – initial experiences from the STRIDA project, Scand. J. Clin. Lab. Invest., 73, 400, 10.3109/00365513.2013.793817 Rosenblum, 2007, Prescription opioid abuse among enrollees into methadone maintenance treatment, Drug Alcohol Depend., 90, 64, 10.1016/j.drugalcdep.2007.02.012 SAS Institute Inc, 2013 Choo, 2014, 1493 Zawilska, 2017, An expanding world of novel psychoactive substances: opioids, Front. Psychiatry, 8, 10.3389/fpsyt.2017.00110 Tran, 2018, 1 Wagner, 2018, 407 Rigga, 2018, Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction, Addict. Behav., 79, 159, 10.1016/j.addbeh.2017.12.024 Van Hout, 2017, Codeine Is My Helper’ : Misuse of and Dependence on Codeine-Containing Medicines in South Africa, Qual. Health Res., 27, 341, 10.1177/1049732315613764 Novak, 2016, Nonmedical use of prescription drugs in the European Union, BMC Psychiatry, 16, 274, 10.1186/s12888-016-0909-3 Manchikanti L, 2010, Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective, Pain Physician, 13, 401, 10.36076/ppj.2010/13/401 “Prescription Opioid Use among Patients Seeking Treatment for Opioid Dependence.;. Jones, 2013, Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – united States, 2002–2004 and 2008–2010, Drug Alcohol Depend., 132, 95, 10.1016/j.drugalcdep.2013.01.007 Rigg, 2018, Opioid-related mortality in rural America: Geographic heterogeneity and intervention strategies, Int. J. Drug Policy, 57, 119, 10.1016/j.drugpo.2018.04.011 Mojtabai, 2017, 1 Mounteney, 2014, Increasing complexity in European drug use: Highlights from the EMCDDA’s 2014 European drug report, Drugs Educ. Prev. Policy, 21, 482, 10.3109/09687637.2014.963516 Boscarino, 2010, Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system, Addiction, 105, 1776, 10.1111/j.1360-0443.2010.03052.x Cao, 2010, Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China, Zhonghua Liu Xing Bing Xue Za Zhi, 31, 269 Edmiston, 2017 Prunuske, 2014, 1 Sokya, 2017, Six-year outcome of opioid maintenance treatment in heroin-dependent patients, Eur. Addict. Res., 23, 97, 10.1159/000468518 Mccarty, 2018, Treatment and Prevention of Opioid Use Disorder : Challenges and Opportunities, Public Health, 39, 525, 10.1146/annurev-publhealth-040617-013526 Greenfield, 2010, Substance abuse in women, Psychiatr. Clin. North Am., 33, 339, 10.1016/j.psc.2010.01.004 Tuchman, 2010, Women and addiction: the importance of gender issues in substance abuse research, J. Addict. Dis., 29, 127, 10.1080/10550881003684582 Deyo, 2015, Opioids for low back pain, BMJ, 350, 10.1136/bmj.g6380 Han, 2017, Prescription opioid use, misuse, and use disorders in U.S. Adults: 2015 national survey on drug use and health, Ann. Intern. Med., 167, 293, 10.7326/M17-0865 McCabe, 2005, Nonmedical use of prescription opioids among U.S. college students: Prevalence and correlates from a national survey, Addict. Behav., 30, 789, 10.1016/j.addbeh.2004.08.024 Kolodny, 2015, The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction, Ssrn NIDA, 2016, 32 Von Korff, 2017, Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives, Int. J. Drug Policy, 46, 90, 10.1016/j.drugpo.2017.05.053 Cicero, 2014, The changing face of heroin use in the United States, JAMA Psychiatry, 71, 821, 10.1001/jamapsychiatry.2014.366 Cicero, 2014 J. CM, “Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers: United States, 2002-2004 and 2008-2010., Drug Alcohol, vol. 132, 1–2, pp. 95–100. CM, 2013, Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010, Drug Alcohol Depend., 132, 95 Bell, 2010, Cycling in and out of treatment ; participation in methadone treatment in NSW, 1990 – 2002, Drug Alcohol Depend., 81, 55 Kidorf, 1994, Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients, Drug Alcohol Depend., 36, 221, 10.1016/0376-8716(94)90148-1 Walley, 2012, Methadone dose, take home status, and hospital admission among methadone maintenance patients alexander, J. Addict. Med., 6, 186, 10.1097/ADM.0b013e3182584772 De Dios, 2019, Nicotine maintenance for smokers in methadone treatment : a new direction, Addict. Res. Theory, 27, 269, 10.1080/16066359.2018.1504032